763888 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
341 A phase Ib expansion cohort of pixatimod plus nivolumab in previously treated, microsatellite stable metastatic colorectal cancer (MSS mCRC) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.341 |
Lemech Charlotte, Dredge Keith, Bampton Darryn, Hammond Edward, Clouson Andrew, Waterhouse Nigel, Stanley Amanda, Leveque-ElMouttie Lucie, Chojnowski Grace, Haydon Andrew, Pavlakis Nick, Burge Matthew, Brown Michael, Goldstein David |
763887 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
3 Development of an integrated method to quantify receptor occupancy for agonist immunotherapeutics that stimulate target cells to migrate from the peripheral blood |
2021-11-01 |
10.1136/jitc-2021-sitc2021.003 |
Gonzalez Louis, Ma Bo, Hernandez Robert, McKay Hannah, Rangwala Fatima, Pandite Lini, Schreiber Taylor |
763886 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
560 Immunotherapeutic and antimetastatic activity of LTX-315 in preclinical models of ICI-resistant breast cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.560 |
Yamazaki Takahiro, Wennerberg Erik, Hensler Michal, Martinez Aitziber Buqué, Kraynak Jeffrey, Fucikova Jitka, Zhou Xi, Sveinbjornsson Baldur, Rekdal Oystein, Demaria Sandra, Galluzzi Lorenzo |
763885 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
96 The impact of radiographic tumor thickness on the complexity of the tumor immune microenvironment in malignant pleural mesothelioma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.096 |
Tomczak Katarzyna, Oliva Jacqueline Liszeth, Zhou Nicolas, Ramos Carlos, Deboeve Nathaniel, Feldman Hope, Lee Percy, Strange Chad, Weissferdt Annikka, Rice David, Mehran Reza, Zhang Jianjun, Tsao Anne, Sepesi Boris, Haymaker Cara |
763884 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
40 Precise spatial multiplexing for immune profiling in non-small cell lung cancer FFPE samples with ChipCytometry |
2021-11-01 |
10.1136/jitc-2021-sitc2021.040 |
Campbell Thomas, Christians Arne, Northcutt Adam, Winkeler Crystal, Gamber Kevin |
763883 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
437 A multicentre phase 1b study of NG-641, a novel transgene-armed and tumour-selective adenoviral vector, and pembrolizumab as neoadjuvant treatment for squamous cell carcinoma of the head and neck |
2021-11-01 |
10.1136/jitc-2021-sitc2021.437 |
Ottensmeier Christian, Evans Mererid, King Emma, Karydis Ioannis, Lillie Tom, Krige David, Lee Jenny, Thomas Matthew, Harrington Kevin |
763882 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
389 Phase II of CD40 agonistic antibody sotigalimab (APX005M) in combination with nivolumab in subjects with metastatic melanoma with confirmed disease progression on anti-PD-1 therapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.389 |
Weiss Sarah, Sznol Mario, Shaheen Montaser, Berciano-Guerrero Miguel-Ángel, Felip Enriqueta, Rodríguez-Abreu Delvys, Arance Ana Maria, Boni Valentina, Linette Gerald, Schuchter Lynn, Gonzalez-Cao Maria, Iannotti Nicholas, Ganti Apar Kishor, Hauke Ralph, Berrocal Alfonso, Filbert Erin, Kluger Harriet |
763881 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
13 DexterTM microfluidic platform coupling single-cell resolution of dynamic tumor-immune interaction with AI for elucidating mechanistic modulation in cancer immunotherapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.013 |
Majumder Pradip, Majumder Biswanath, Singh Ranjeet, Sane Abhay, Manglik Rushil, Keshari Ravi, Mohanasundaram M, Lal Ashwin |
763880 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
605 NHS-IL12 plus Entinostat combination effectively targets anti-PD-1/PD-L1 checkpoint resistant murine tumors harboring MHC Class I and antigen processing machinery deficiency |
2021-11-01 |
10.1136/jitc-2021-sitc2021.605 |
Minnar Christine, Chariou Paul, Hicks Kristin, Schlom Jeffrey, Gameiro Sofia |
763879 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
633 Incorporating checkpoint inhibitors into cancer care: a study of the impact of digital education on clinical competence and practice patterns |
2021-11-01 |
10.1136/jitc-2021-sitc2021.633 |
Ackbarali Tariqa, Nido Elizabeth del, Rini Brian, Overman Michael, Witsuba Ignacio |